HLB BioStep Co Ltd Ordinary Shares 278650
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 3,570.00
- Day Range
- KRW 3,530.00–3,620.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 3,540.00 / KRW 3,545.00
- Market Cap
- KRW 300.13 Bil
- Volume/Avg
- 300,762 / 4.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.14
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.47%
Company Profile
HLB BioStep Co Ltd provides non-clinical services necessary for leading domestic and foreign pharmaceutical companies and bio ventures in the process of developing drugs and health functional foods.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 182
- Website
- http://www.knotus.co.kr
Comparables
Valuation
|
Metric
|
278650
|
085660
|
107590
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 12.09 |
Price/Book Value | 2.79 | 3.41 | 0.78 |
Price/Sales | 5.14 | 1.06 | 0.41 |
Price/Cash Flow | 95.20 | 36.24 | 9.12 |
Price/Earnings
278650
085660
107590
Financial Strength
|
Metric
|
278650
|
085660
|
107590
|
|---|---|---|---|
Quick Ratio | 1.19 | 0.73 | 0.65 |
Current Ratio | 1.23 | 0.83 | 1.23 |
Interest Coverage | 0.67 | 0.67 | 4.42 |
Quick Ratio
278650
085660
107590
Profitability
|
Metric
|
278650
|
085660
|
107590
|
|---|---|---|---|
Return on Assets (Normalized) | −1.68% | −0.51% | 3.42% |
Return on Equity (Normalized) | −3.16% | −2.90% | 7.38% |
Return on Invested Capital (Normalized) | −0.82% | 0.33% | 5.39% |
Return on Assets
278650
085660
107590
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Lrdrkkhf | Blkr | $572.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Lvfrnbky | Dwcsvph | $103.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Qkjrpph | Yljjs | $99.2 Bil | |
MRNA
| Moderna Inc | Mhxhcwjvv | Ylm | $42.7 Bil | |
ARGX
| argenx SE ADR | Ylhvbgqq | Jrwv | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Hyjznrwkw | Nymb | $21.7 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Cnyvmnxz | Nvcdkt | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Fjdhzqz | Fjcrqvd | $15.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Tttzkrjqj | Gprjhg | $12.7 Bil | |
INCY
| Incyte Corp | Bvrhqxcr | Zxdyn | $11.9 Bil |